FBIO (STOCKS)
Fortress Biotech, Inc.
$2.860000
+0.090000 (+3.25%)
Prev close: $2.770000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Lindsay Allan Rosenwald
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $95.01M
- Employees
- 101
- P/E (TTM)
- 0.87
- P/B (TTM)
- 0.57
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.01 | $0.11 | -0.1222 | -108.91% |
|
Sep 2025 (Q3)
|
$0.11 | $-0.43 | +0.5384 | +125.68% |
|
Jun 2025 (Q2)
|
$-0.50 | $-0.37 | -0.1328 | -36.17% |
|
Mar 2025 (Q1)
|
$-0.48 | $-0.50 | +0.0249 | +4.93% |
Financial Statements
| Revenues | $66.16M |
| Benefits Costs and Expenses | -$67.12M |
| Cost Of Revenue | $22.35M |
| Costs And Expenses | $121.97M |
| Gross Profit | $43.81M |
| Nonoperating Income/Loss | $189.09M |
| Operating Expenses | $99.62M |
| Selling, General, and Administrative Expenses | $86.80M |
| Other Operating Expenses | $12.83M |
| Operating Income/Loss | -$55.81M |
| Income/Loss From Continuing Operations After Tax | $128.94M |
| Income/Loss From Continuing Operations Before Tax | $133.28M |
| Income Tax Expense/Benefit | $4.34M |
| Net Income/Loss | $128.94M |
| Net Income/Loss Attributable To Noncontrolling Interest | $1.17M |
| Net Income/Loss Attributable To Nonredeemable Noncontrolling Interest | -$1.17M |
| Net Income/Loss Attributable To Parent | $127.77M |
| Net Income/Loss Available To Common Stockholders, Basic | $119.20M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $8.57M |
| Preferred Stock Dividends And Other Adjustments | $8.57M |
| Basic Earnings Per Share | $3.84 |
| Diluted Earnings Per Share | $3.17 |
| Basic Average Shares | 86,491,122 |
| Diluted Average Shares | 98,543,752 |
| Assets | $356.87M |
| Current Assets | $295.48M |
| Inventory | $9.29M |
| Other Current Assets | $286.19M |
| Noncurrent Assets | $61.39M |
| Fixed Assets | $2.43M |
| Other Non-current Assets | $58.97M |
| Liabilities | $154.50M |
| Current Liabilities | $103.39M |
| Accounts Payable | $14.14M |
| Other Current Liabilities | $89.25M |
| Noncurrent Liabilities | $51.11M |
| Long-term Debt | $37.50M |
| Other Non-current Liabilities | $13.61M |
| Equity | $202.37M |
| Equity Attributable To Noncontrolling Interest | $40.17M |
| Equity Attributable To Parent | $162.21M |
| Liabilities And Equity | $356.87M |
| Net Cash Flow From Operating Activities | $157.64M |
| Net Cash Flow From Operating Activities, Continuing | $157.64M |
| Net Cash Flow From Investing Activities | -$167.50M |
| Net Cash Flow From Investing Activities, Continuing | -$167.50M |
| Net Cash Flow From Financing Activities | -$2.09M |
| Net Cash Flow From Financing Activities, Continuing | -$2.09M |
| Net Cash Flow | -$11.96M |
| Net Cash Flow, Continuing | -$11.96M |
| Comprehensive Income/Loss | $128.94M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $128.94M |
| Other Comprehensive Income/Loss | $0.00 |